Psychopharmacology in children and adolescents: unmet needs …
2023年12月7日 · We present and discuss the evidence base for medications currently used for mental disorders in children and adolescents, medications in the pipeline, opportunities in the development of novel medications, crucial priorities for the conduct of future clinical studies, challenges and opportunities in terms of the regulatory and legislative framew...
Psychopharmacology in children and adolescents: unmet needs …
Psychopharmacological treatment is an important component of the multimodal intervention approach to treating mental health conditions in children and adolescents. Currently, there are many unmet needs but also opportunities, alongside possible risks to consider, regarding the pharmacological treatm …
Pediatric Psychopharmacology for Depressive and Anxiety …
2022年4月22日 · This article summarizes the evidence base for psychopharmacologic interventions; the developmental pharmacology of selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); and pharmacokinetic and pharmacodynamic differences between youths and adults …
Psychopharmacology in children and adolescents: unmet needs …
2024年2月1日 · We present and discuss the evidence base for medications currently used for mental disorders in children and adolescents, medications in the pipeline, opportunities in the development of novel medications, crucial priorities for the conduct of future clinical studies, challenges and opportunities in terms of the regulatory and legislative framew...
Psychopharmacology of Pediatric Anxiety Disorders: A Narrative …
Psychotherapy, particularly cognitive behavioral therapy as a stand-alone treatment or in combination with medication, is found to be efficacious in the treatment of various anxiety disorders. The early recognition and treatment of anxiety disorders result in better long-term outcomes in children and adolescents.
increasingly used in child and adolescent psychiatry around the world. From the serendipitous discovery by Bradley of the effects of amphetamines on child hyperactivity in 1937 to the multisite clinical trials of the 21st century, pediatric psychopharmacology has evolved from an area of research to a standard of clinical
Psychopharmacology for children: from off label use to ... - PubMed
Pharmacological treatment of children and adolescents is largely based on evidence from adults' studies. There is, however, growing awareness that this evidence cannot simply be extrapolated to children. The Dutch Medicines Evaluation Board (MEB) in collaboration with the Child and Adolescent sectio …
psychopharmacology for children and adolescents • Recognize that prescribing of medication to children and adolescents is an individual, family and system intervention. • Emphasize on the developmental issues that need to be considered for the successful intervention. • Medication consultations may be better understood as
134: Psychopharmacology in Children - American Academy of …
Psychopharmacologic agents are being used with increased frequency in the pediatric population. Approximately 50% of children and adolescents will, at some point before age 18 years, meet criteria for a psychiatric diagnosis. Almost 25% of children will have substantial impairment as a result of those symptoms.
Psychopharmacology in Children and Adolescents - ResearchGate
2022年1月1日 · This article will present an overview of psychopharmacological treatment of the most common psychiatric conditions in youth, including attention deficit hyperactivity disorder, mood and anxiety...
跳至内容